Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
New scoring system identifies kidney outcome with radiation therapy in acute renal allograft rejection
L M Chen, J Godinez, R A Thisted, et al.
Cancer Treatment and Research
|
January 1, 1995
Cellular and molecular mechanisms of radioresistance
R R Weichselbaum, M A Beckett, E E Vokes, et al.
Seminars in Oncology
|
June 1, 1995
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer
E E Vokes, R Stupp, D Haraf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1988
In vitro radiobiological parameters of human sarcoma cell lines
R R Weichselbaum, M A Beckett, M A Simon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1990
Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters
J C Roeske, G T Chen, R W Atcher, et al.
Cancer Research
|
September 1, 1992
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer
D G Brachman, D Graves, E Vokes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2001
Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience
P P Connell, L Ignacio, D Haraf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?
M A List, J Stracks, L Colangelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1993
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis
E E Vokes, M J Ratain, R Mick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
T Y Seiwert, T Darga, D Haraf, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
New scoring system identifies kidney outcome with radiation therapy in acute renal allograft rejection
L M Chen, J Godinez, R A Thisted, et al.
Cancer Treatment and Research
|
January 1, 1995
Cellular and molecular mechanisms of radioresistance
R R Weichselbaum, M A Beckett, E E Vokes, et al.
Seminars in Oncology
|
June 1, 1995
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer
E E Vokes, R Stupp, D Haraf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1988
In vitro radiobiological parameters of human sarcoma cell lines
R R Weichselbaum, M A Beckett, M A Simon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1990
Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters
J C Roeske, G T Chen, R W Atcher, et al.
Cancer Research
|
September 1, 1992
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer
D G Brachman, D Graves, E Vokes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2001
Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience
P P Connell, L Ignacio, D Haraf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?
M A List, J Stracks, L Colangelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1993
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis
E E Vokes, M J Ratain, R Mick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
T Y Seiwert, T Darga, D Haraf, et al.
Page
of 3